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Human APOBEC3G inhibits the repli-
cation of Vif-deficient HIV-1 by hypermu-
tating nascent viral cDNA (reviewed in [1–
3]). Zheng and colleagues recently reported
that the HIV-1 restriction activity of
APOBEC3G requires a cellular co-factor
[4]. Their conclusion depended on three
critical observations: i) CEM-T4 cells sup-
port the replication of Vif-deficient HIV-1,
ii) CEM-T4 cells express restrictive levels
of APOBEC3G, and iii) CEM-T4 cells
engineered to express more APOBEC3G
still permitted Vif-deficient HIV-1 replica-
tion [4]. These observations suggested that
APOBEC3G alone is insufficient for restric-
tion, and together with subsequent cell
fusion experiments, that a recessive cellular
co-factor is required. However, the fact that
APOBEC3G is capable of restricting a
broad number of retroelements, including
yeast Ty elements, strongly suggests that
other human cellular proteins are not
absolutely required for restriction (e.g.,
[5,6] and reviewed in [1–3]).
An alternative explanation that could
account for the observed permissive phe-
notype of the CEM-T4 line is that it is
mixed, composed of a population of cells
expressing low and/or variable levels of
APOBEC3G. If this were the case, then the
permissive phenotype could simply be due
to virus replication in the subset of cells
expressing low levels of APOBEC3G. To
address this hypothesis, we generated
subclones of the CEM-T4 line by serial
dilution and determined the level of
APOBEC3G expression by immunoblot-
ting (Figure 1A). First, we observed that
CEM-T4 cells expressed levels of APO-
BEC3G that were considerably lower than
those in the non-permissive line CEM,
regardless of whether they were obtained
from the AIDS Research and Reference
Reagent Program (CEM-T4-A) or directly
from the Zheng laboratory (CEM-T4-Z).
Second, we found that representative
CEM-T4 subclones, regardless of source,
expressed both low and variable APO-
BEC3G levels. It is further notable that
none of the subclones expressed fully non-
permissive, CEM-like APOBEC3G levels.
This heterogeneity is reflected by the
kinetics of Vif-deficient virus replication,
with some subclones being fully permissive
andothersbeingsemi-permissive(Figure1B
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Figure 1. CEM-T4 cells express low APOBEC3G levels and subclones show additional
heterogeneity. (A) An immunoblot showing APOBEC3G expression levels in CEM, CEM-SS, CEM-
T4, and CEM-T4 subclones. The CEM-T4 line was obtained from both the AIDS Research and
Reference Reagent Program (courtesy of Dr. J. P. Jacobs) and Y.-H. Zheng (Michigan State
University [4]), designated CEM-T4-A and CEM-T4-Z, respectively. CEM-T4 subclones A1-5 and Z1-
5 were obtained by expanding single cells. The anti-APOBEC3G (A3G) antibody was provided by J.
Lingappa (University of Washington) through the AIDS Research and Reference Reagent Program,
and the anti-tubulin (TUB) antibody was from Covance. (B and C) Replication kinetics of Vif-
deficient HIV-1 (IIIB [8,9]) on the indicated lines or subclones. Virus replication was monitored by
mixing cell-free culture supernatant with the reporter cells CEM-GFP, and infectivity was
determined by determining the percentage of GFP-positive CEM-GFP cells by flow cytometry
[7,8].
doi:10.1371/journal.ppat.1000528.g001
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strated that APOBEC3G levels are both
low and variable within individual cells of
the CEM-T4 line, thus providing a reason-
able molecular explanation for the permis-
sive phenotype of this cell line.
Curiously, Zheng and coworkers [4]
also showed that CEM-T4 cells retroviral-
ly transduced with APOBEC3G were still
permissive for Vif-deficient HIV-1 repli-
cation. This result may be due to the
distinct possibility that APOBEC3G itself
inactivated some of the transducing viral
cDNAs. Such an attempt at complemen-
tation would probably result in a CEM-T4
line that is mixed for APOBEC3G expres-
sion. To clarify this important point, we
used electroporation to generate panels of
HA-tagged and untagged APOBEC3G-
expressing CEM-T4 clones and used them
for virus replication experiments (Figures 2
and 3, respectively).
Contrary to the findings of Zheng and
colleagues [4], our APOBEC3G-expressing
CEM-T4 clones were fully restrictive for Vif-
deficient HIV-1 replication. The observed
non-permissive phenotype was not due to
gross overexpression of APOBEC3G be-
causemanyof the restrictive CEM-T4clones
stably expressed APOBEC3G to levels
slightly lower to those of CEM, the original
parent of CEM-T4 (e.g., clone G4 in
Figure 3). It is also notable that some vector
control clones such as V9, like the subclones
inFigure1, expressed low and non-restrictive
levels of APOBEC3G. These data suggest
that cells must pass an APOBEC3G expres-
sion ‘‘threshold’’ before they become fully
non-permissive for Vif-deficient HIV-1.
Nevertheless, together these virus replication
data clearly demonstrated that expression of
exogenous APOBEC3G is sufficient to
render CEM-T4 cells non-permissive for
Vif-deficient HIV-1 replication. We con-
clude that this cell line does not require a
specific endogenous APOBEC3G ‘‘co-fac-
tor’’ to restrict Vif-deficient HIV-1.
In this report, we question the obligate
APOBEC3G co-factor hypothesis put forth
by Zheng and colleagues [4]. Our data
clearly provide an alternative explanation
that—rather than lacking a co-factor for
APOBEC3G—the CEM-T4 line is mixed
with individual cells expressing heteroge-
neous and less-than-restrictive levels of
APOBEC3G. Importantly, when transfec-
tions were used to generate stable APO-
BEC3G-expressing CEM-T4 clones, the
resulting lines were non-permissive for Vif-
deficient HIV-1 replication. Based on these
results, we conclude that CEM-T4 cells do
not lack an APOBEC3G co-factor and,
more generally, that APOBEC3G may not
strictly require another cellular protein for
HIV-1 restriction. However, we would like
to emphasize that neither study rules out
the attractive possibility that APOBEC3G,
like most other proteins, is likely to be
regulated by a variety of cellular processes.
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symbols represent virus replication on APO-
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APOBEC3G-expressing CEM-T4 clones (G4 and
G7), vector clones (V6 and V9), parental CEM-T4,
CEM, and CEM-SS cells. These clones were
generated by electroporating an APOBEC3G or
vector-control plasmid into CEM-T4-A cells,
followed by clone outgrowth in 96-well plates
in selective media containing G418. The anti-
APOBEC3G (A3G) antibody was provided by J.
Lingappa (University of Washington) through
the AIDS Research and Reference Reagent
Program and the anti-tubulin (TUB) antibody
was purchased from Covance. (B and C)
Replication kinetics of Vif-deficient or Vif-profi-
cient HIV-1, respectively, on the indicated clones.
Solid lines and filled symbols represent virus
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dashed lines and open symbols represent virus
r e p l i c a t i o no nv e c t o r - c o n t r o lc l o n e s .
doi:10.1371/journal.ppat.1000528.g003
PLoS Pathogens | www.plospathogens.org 2 July 2009 | Volume 5 | Issue 7 | e10005285. Dutko JA, Schafer A, Kenny AE, Cullen BR,
Curcio MJ (2005) Inhibition of a yeast LTR
retrotransposon by human APOBEC3 cytidine
deaminases. Curr Biol 15: 661–666.
6. Schumacher AJ, Nissley DV, Harris RS (2005)
APOBEC3G hypermutates genomic DNA and
inhibits Ty1 retrotransposition in yeast. Proc Natl
Acad Sci U S A 102: 9854–9859.
7. Gervaix A, West D, Leoni LM, Richman DD,
Wong-Staal F, et al. (1997) A new reporter cell
line to monitor HIV infection and drug suscep-
tibility in vitro. Proc Natl Acad Sci U S A 94:
4653–4658.
8. Hache ´ G, Shindo K, Albin JS, Harris RS (2008)
Evolution of HIV-1 isolates that use a novel Vif-
independent mechanism to resist restriction by
human APOBEC3G. Curr Biol 18: 819–824.
9. Sheehy AM, Gaddis NC, Choi JD, Malim MH
(2002) Isolation of a human gene that inhibits
HIV-1 infection and is suppressed by the viral Vif
protein. Nature 418: 646–650.
PLoS Pathogens | www.plospathogens.org 3 July 2009 | Volume 5 | Issue 7 | e1000528